Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
XRAY Stock Forecast 2026-2027
$10.26
Current Price
$2.06B
Market Cap
Buy 4
Hold 11
Sell 2
Wall St Analyst Ratings
Distance to XRAY Price Targets
+65.7%
To High Target of $17.00
+26.7%
To Median Target of $13.00
-12.3%
To Low Target of $9.00
XRAY Price Momentum
+4.4%
1 Week Change
-6.7%
1 Month Change
-36.8%
1 Year Change
-10.2%
Year-to-Date Change
-40.0%
From 52W High of $17.09
+9.0%
From 52W Low of $9.41
📊 TOP ANALYST CALLS
Did XRAY Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if DENTSPLY SIRONA is one of their latest high-conviction picks.
Latest XRAY Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, XRAY has a neutral consensus with a median price target of $13.00 (ranging from $9.00 to $17.00). The overall analyst rating is Buy (6.4/10). Currently trading at $10.26, the median forecast implies a 26.7% upside. This outlook is supported by 4 Buy, 11 Hold, and 2 Sell ratings.
Conversely, the most conservative target is provided by Glen Santangelo at Barclays, suggesting a 12.3% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
XRAY Analyst Ratings
4
Buy
11
Hold
2
Sell
XRAY Price Target Range
Low
$9.00
Average
$13.00
High
$17.00
Current: $10.26
Latest XRAY Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for XRAY.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 4, 2026 | Barclays | Glen Santangelo | Underweight | Maintains | $9.00 |
| May 7, 2026 | UBS | Buy | Maintains | $N/A | |
| May 6, 2026 | Mizuho | Neutral | Maintains | $N/A | |
| Apr 15, 2026 | Citigroup | Sell | Initiates | $N/A | |
| Mar 2, 2026 | Mizuho | Neutral | Maintains | $N/A | |
| Mar 2, 2026 | Barrington Research | Outperform | Maintains | $N/A | |
| Feb 27, 2026 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Feb 27, 2026 | Evercore ISI Group | In-Line | Maintains | $N/A | |
| Feb 27, 2026 | Baird | Neutral | Maintains | $N/A | |
| Feb 19, 2026 | B of A Securities | Buy | Upgrade | $N/A | |
| Feb 3, 2026 | UBS | Buy | Maintains | $N/A | |
| Jan 20, 2026 | Mizuho | Neutral | Maintains | $N/A | |
| Jan 5, 2026 | Barrington Research | Outperform | Maintains | $N/A | |
| Dec 16, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Dec 16, 2025 | Baird | Neutral | Maintains | $N/A | |
| Dec 9, 2025 | Barclays | Underweight | Initiates | $N/A | |
| Nov 10, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Nov 7, 2025 | JP Morgan | Neutral | Maintains | $N/A | |
| Nov 7, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Nov 7, 2025 | William Blair | Market Perform | Downgrade | $N/A |
Dentsply Sirona Inc. (XRAY) Competitors
The following stocks are similar to DENTSPLY SIRONA based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
XRAY
DENTSPLY SIRONA
mkt cap
2.00B
Dentsply Sirona Inc. (XRAY) Financial Data
Dentsply Sirona Inc. has a market capitalization of $2.06B with a P/E ratio of -3.4x. The company generates $3.68B in trailing twelve-month revenue with a -17.1% profit margin.
Revenue growth is +0.1% quarter-over-quarter, while maintaining an operating margin of +3.4% and return on equity of -37.7%.
Valuation Metrics
Market Cap
$2.06B
Enterprise Value
$4.16B
P/E Ratio
-3.4x
PEG Ratio
0.0x
Price/Sales
0.5x
Growth & Margins
Revenue Growth (YoY)
+0.1%
Gross Margin
+48.5%
Operating Margin
+3.4%
Net Margin
-17.1%
EPS Growth
+0.1%
Financial Health
Cash/Price Ratio
+9.2%
Current Ratio
1.5x
Debt/Equity
177.8x
ROE
-37.7%
ROA
+2.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Dentsply Sirona Inc. (XRAY) Business Model
About Dentsply Sirona Inc.
What They Do
Develops and markets dental products and technologies.
Business Model
The company operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. It generates revenue by selling a range of dental equipment, consumables, and healthcare products, catering to dental professionals and healthcare providers.
Additional Information
Founded in 1899 and headquartered in Charlotte, North Carolina, the company is focused on advancing oral health technologies and specialized medical consumables, playing a significant role in enhancing diagnostics and patient care in dentistry.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
14,000
CEO
Mr. Daniel T. Scavilla
Country
United States
IPO Year
1991
Website
www.dentsplysirona.comDentsply Sirona Inc. (XRAY) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Dentsply (XRAY) Down 13.5% Since Last Earnings Report: Can It Rebound?
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Jun 04, 2026
By Zacks Equity Research
Realtime BLOG
Latest News
Quick Summary
Shareholders can discuss their rights and options at no cost. Legal matters will be handled on a contingent fee basis, with no upfront payment required.
Why It Matters
Shareholder engagement signals potential legal issues or disputes, which may affect stock performance and investor confidence. Legal costs on a contingent basis may indicate serious concerns.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Dentsply (XRAY) reported earnings 30 days ago; investors may want to monitor upcoming developments for potential stock movements.
Why It Matters
Earnings reports can indicate a company's financial health and growth potential, impacting stock performance and investor sentiment. Upcoming developments may influence Dentsply's stock valuation.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
DENTSPLY SIRONA Inc. (XRAY) presented at the Stifel Jaws & Paws Conference 2026, providing insights into their business and future strategies. Details available in the transcript.
Why It Matters
DENTSPLY SIRONA's presentation at the Stifel conference can signal future growth prospects and strategic directions, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Dentsply Sirona (Nasdaq: XRAY) has enhanced its U.S. distribution by expanding its partnership with Nashville Dental, Inc., boosting its presence in the Southeast and Mid-Atlantic regions.
Why It Matters
Dentsply Sirona's expanded partnership with Nashville Dental enhances its distribution capabilities, likely increasing market share and revenue growth in key regions, positively impacting investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) will present at the 2026 Stifel Jaws & Paws Conference on May 27, 2026, at 3:35 p.m. ET.
Why It Matters
Dentsply Sirona's participation in the Stifel Jaws & Paws Conference may provide insights into its growth strategy and market position, influencing investor sentiment and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
DENTSPLY SIRONA's stock declined following Q1 earnings that fell short of estimates, as margin pressures impacted revenue growth in important healthcare segments.
Why It Matters
DENTSPLY SIRONA's Q1 earnings miss signals potential issues with profitability despite revenue growth, raising concerns about future performance and investment viability.
Source: Zacks Investment Research
Market Sentiment:
Negative
Frequently Asked Questions About XRAY Stock
What is Dentsply Sirona Inc.'s (XRAY) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Dentsply Sirona Inc. (XRAY) has a median price target of $13.00. The highest price target is $17.00 and the lowest is $9.00.
Is XRAY stock a good investment in 2026?
According to current analyst ratings, XRAY has 4 Buy ratings, 11 Hold ratings, and 2 Sell ratings. The stock is currently trading at $10.26. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for XRAY stock?
Wall Street analysts predict XRAY stock could reach $13.00 in the next 12 months. This represents a 26.7% increase from the current price of $10.26. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Dentsply Sirona Inc.'s business model?
The company operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. It generates revenue by selling a range of dental equipment, consumables, and healthcare products, catering to dental professionals and healthcare providers.
What is the highest forecasted price for XRAY Dentsply Sirona Inc.?
The highest price target for XRAY is $17.00 from at , which represents a 65.7% increase from the current price of $10.26.
What is the lowest forecasted price for XRAY Dentsply Sirona Inc.?
The lowest price target for XRAY is $9.00 from Glen Santangelo at Barclays, which represents a -12.3% decrease from the current price of $10.26.
What is the overall XRAY consensus from analysts for Dentsply Sirona Inc.?
The overall analyst consensus for XRAY is neutral. Out of 2 Wall Street analysts, 4 rate it as Buy, 11 as Hold, and 2 as Sell, with a median price target of $13.00.
How accurate are XRAY stock price projections?
Stock price projections, including those for Dentsply Sirona Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 9, 2026 8:55 AM UTC